LB To

1.6k total citations
17 papers, 1.4k citations indexed

About

LB To is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, LB To has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 11 papers in Immunology and 5 papers in Oncology. Recurrent topics in LB To's work include Hematopoietic Stem Cell Transplantation (13 papers), Immune cells in cancer (8 papers) and Acute Myeloid Leukemia Research (5 papers). LB To is often cited by papers focused on Hematopoietic Stem Cell Transplantation (13 papers), Immune cells in cancer (8 papers) and Acute Myeloid Leukemia Research (5 papers). LB To collaborates with scholars based in Australia and United States. LB To's co-authors include CA Juttner, DN Haylock, PJ Simmons, LK Ashman, RJ Levinsky, D. Van Epps, JG Bender, SC Clark, MA Vadas and Angel F. López and has published in prestigious journals such as Blood, Leukemia and Bone Marrow Transplantation.

In The Last Decade

LB To

17 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
LB To Australia 12 894 554 370 267 251 17 1.4k
T Leemhuis United States 18 753 0.8× 552 1.0× 256 0.7× 287 1.1× 317 1.3× 27 1.2k
EF Srour United States 16 849 0.9× 491 0.9× 279 0.8× 307 1.1× 288 1.1× 25 1.3k
RJ Berenson United States 10 870 1.0× 381 0.7× 317 0.9× 253 0.9× 286 1.1× 16 1.2k
DN Haylock Australia 12 1.5k 1.6× 562 1.0× 630 1.7× 447 1.7× 307 1.2× 20 1.9k
JD Cashman Canada 15 962 1.1× 353 0.6× 397 1.1× 506 1.9× 389 1.5× 24 1.5k
SG Emerson United States 20 1.0k 1.1× 579 1.0× 404 1.1× 454 1.7× 424 1.7× 34 1.8k
MR Loken United States 11 1.1k 1.2× 725 1.3× 266 0.7× 353 1.3× 493 2.0× 13 1.8k
SH Bartelmez United States 16 666 0.7× 428 0.8× 318 0.9× 253 0.9× 409 1.6× 26 1.2k
Charlotte Brovall United States 7 525 0.6× 356 0.6× 193 0.5× 202 0.8× 311 1.2× 10 1.1k
R. J. Berenson United States 9 780 0.9× 377 0.7× 230 0.6× 218 0.8× 163 0.6× 21 1.1k

Countries citing papers authored by LB To

Since Specialization
Citations

This map shows the geographic impact of LB To's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LB To with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LB To more than expected).

Fields of papers citing papers by LB To

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by LB To. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LB To. The network helps show where LB To may publish in the future.

Co-authorship network of co-authors of LB To

This figure shows the co-authorship network connecting the top 25 collaborators of LB To. A scholar is included among the top collaborators of LB To based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with LB To. LB To is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Nivison‐Smith, Ian, KF Bradstock, Jeff Szer, et al.. (2001). Allogeneic haemopoietic cell transplants in Australia, 1996 – A multi-centre retrospective comparison of the use of peripheral blood stem cells with bone marrow. Bone Marrow Transplantation. 28(1). 21–27. 13 indexed citations
2.
Dyson, P., Noemi Horvath, D. Joshua, et al.. (2000). CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilisation in multiple myeloma. Bone Marrow Transplantation. 25(11). 1175–1184. 22 indexed citations
4.
Haylock, DN, et al.. (1997). Peripheral blood is a source of BCR-ABL-negative pre-progenitors in early chronic phase chronic myeloid leukemia. Leukemia. 11(4). 581–587. 9 indexed citations
7.
Haylock, DN, et al.. (1992). Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood. 80(6). 1405–1412. 240 indexed citations
8.
Haylock, DN, et al.. (1992). Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood. 80(6). 1405–1412. 297 indexed citations
9.
Ashman, LK, et al.. (1991). Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood. 78(1). 30–37. 165 indexed citations
10.
Ashman, LK, et al.. (1991). Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood. 78(1). 30–37. 13 indexed citations
15.
López, Angel F., P. Dyson, LB To, et al.. (1988). Recombinant human interleukin-3 stimulation of hematopoiesis in humans: loss of responsiveness with differentiation in the neutrophilic myeloid series. Blood. 72(5). 1797–1804. 9 indexed citations
16.
To, LB, et al.. (1983). The effect of monocytes in the peripheral blood CFU-C assay system. Blood. 62(1). 112–117. 25 indexed citations
17.
To, LB, et al.. (1983). The effect of monocytes in the peripheral blood CFU-C assay system. Blood. 62(1). 112–117. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026